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t571 ABSTRACT 
A medication infusion system having a means for pro- 
viding an informational signal when (1) medication in 
the reservoir falls below a threshold level; (2) a fluid 
leak occurs in different portions of the system; and (3) 
the intended medication pumping does not correlate 
with the pumping actually affected. 
5 Claims, 5 Drawing Sheets 
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APPARATUS FOR DETECTING A CONDITION OF 
A MEDICATION INFUSION SYSTEM AND 
PROVIDING AN INFORMATIONAL SIGNAL IN 
RESPONSE THERETO 
STATEMENT OF GOVERNMENTAL INTEREST 
The invention described herein was made in the per- 
formance of work under NASA Contract No. NDPR 
S-6383B and is subject to the provisions of Section 305 
of the National Aeronautics and Space Act of 1958 (72 
Stat. 435; 42 U.S.C. 2457). 
REFERENCETORELATEDCASES 
This is a divisional of pending U.S. Pat. application 
filed on Nov. 4, 1982, Ser. No. 439,139 now issued into 
U.S. Pat. No. 4,619,653, which in turn is a continuation 
in part of Ser. No. 034,155 filed on Apr. 27, 1979, and 
now U.S. Pat. No. 4,373,527. The inventor in the related 
cases was Robert E. Fischell. 
FIELD OF THE INVENTION 
The present invention relates to apparatus for detect- 
ing selected conditions, including deviations in nominal 
performance, in a system for dispensing medication to a 
living being. Although mainly intended for use with 
human patients requiring infusions of a drug, such as 
insulin, morphine, heparin, or any of various other che- 
motherapeutic agents, the invention extends to use in 
any living body (such as domestic animals) and to the 
infusion of any liquid (such as blood) or colloidal sus- 
pension, or gas or granulated solid, which may be dis- 
pensed by the system and many provide a curative or 
healing effect. Although a principal use of the invention 
is in implantable devices, the principles of the invention 
also apply to systems external to a living being for the 
infusion of medication. 
TECHNOLOGICAL CONTEXT OF THE 
INVENTION 
Various techniques and devices have been suggested 
and are currently under study which address the prob- 
lem of dispensing a drug or other medicative liquid into 
a living body. Of these techniques and devices, how- 
ever, the provision of redundant safety features and the 
indication of certain vital operation conditions are 
rarely addressed and then to only a limited extent. 
One liquid infusion device discussed in U.S. Pat. No. 
4.077,405 by Haerton et a1 discloses a controllable dos- 
ing arrangement which provides for human operator 
interaction. A syringe forces liquid through a pressure 
valve into a supply reservoir and a bellows pump forces 
drug from the reservoir through a flow limiter into the 
body. The Haerton et a1 patent teaches an “overpres- 
sure’’ technique where liquid in the reservoir is at a 
pressure above that at the discharge point. This device 
fails to address various safety problems such as leakage, 
excessive pumping, and excessive requests for drug. In 
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penser having a bellows pump which is fed through and 
expels drug through valves, in particular one-way 
valves. The Ellinwood device is not programmable; it 
varies dosage by opening and closing portals or select- 
ing a dose of medication from one of a plurality of 
pumps having different dosage volumes and/or differ- 
ent medications stored therein. System operation relat- 
ing to pressure integrity checks during filling, leakage 
problems, patient and doctor interaction with the dis- 
penser, and dosage input programming, and informa- 
tional outputs which correspond to such system opera- 
tion conditions are not considered. 
An invention of Blackshear (U.S. Pat. No. 3,731,681) 
shows another infusion pump without such features. 
While disclosing an implanted bellows pump arrange- 
ment fed through a self-sealing plug, the Blackshear 
pump does not look for pressure integrity before filling 
the device with drug. Further, because there is no input 
check valve and because the pressure in the device is 
above that of the body in which it is implanted, leakage 
in Blackshear can be dangerous. This is particularly true 
because the full reservoir will typically contain a lethal 
dose of medication if delivered over a short period of 
time. It is thus particularly significant that no means for 
indicating to a patient either proper or non-optimal 
performance is provided. 
Richter (U.S. Pat. No. 3,894,538) considers, in a med- 
icine supplying device, one safety feature: an exit plug 
for preventing contaminants from entering the device 
and for limiting drug outflow. However, redundant 
safety backed up by an informational signal providing 
feature is absent. 
A device by Jacob (US. Pat. No. 4,033,479) provides 
a bellows pump which maintains drug in a chamber at a 
“constant internal pressure.” A valve opens to release 
drug from the chamber into a body. The bellows varies 
the chamber volume to maintain constant pressure. It is 
not of importance to Jacob how much pressure there is 
40 in the chamber-it is above body pressure-but, rather, 
the concern is to keep pressure constant. Leakage out 
from the valve and the spurting of drug into the body 
under relatively high constant pressure would appear to 
be problems inherent in the Jacob device. Apparatus 
45 informing a patient of such conditions or other such 
conditions is not present. 
Portner in U.S. Pat. No. 4,126,132 and its predecessor 
case, Ser. No. 599330 filed July 28, 1976, discuss the use 
of alarms in an intravenous delivery system. Sensors for 
50 detecting air in the delivery lines by making pressure 
measurements and sensors for detecting the amount of 
fluid in a supply bottle provide input to an audible or 
visual alarm. The use of alarms for a broad variety of 
55 conditions-which alarms would increase the safety of 
the system-is not discussed. Furthermore, the applica- 
tion of alarms to implantable medication release systems 
is not considered. - -  
particular, should the input control-valve in this pa- Franetzki et a1 U.S. Pat. NO. 4,191,181 suggests the 
tented device leak, a flood of liquid would enter the 60 use of negative Pressure, external to the medication 
body because of the pressure differentid and the lack of reservoir, as a Safety feature in a medication dispensing 
any back-up safety mechanism. No provision for detect- unit. However, this reference has no teaching of means 
ing leaks in the device, for signalling selected deviation for detecting and alerting the patient and/or physician 
in nominal performance, for restricting the number of regarding the structural and operational state of the 
or quantity of drug doses, or for monitoring proper 65 unit, so as to provide information regarding e.g. leaks 
operation of the device is suggested. detected within the unit, excessive medication requests, 
Like Haerton et al, Ellinwood in US. Pat. No. stored medication level, blockage of the medication 
3,692,027 teaches an implanted, self-powered drug dis- dispenser’s output, etc. 
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Several recent publications have also underscored the impeding filter. A pressure build-up in the medication 
advantages of a medication infusion device which is reservoir would be detected and an informational signal 
implantable. Two articles by Rhode et a1 (“One Year of generated, indicating that the relative negative pressure 
Heparin Anti-coagulation;” Minnesota Medicine; Octo- in the medication reservoir had increased. On the one 
ber, 1977 and “Protracted Parenteral Drug Infusion in 5 hand, the likelihood of a leak out is diminished and, on 
Ambulatory Subjects Using an Implantable Infusion the other, the patient is informed if a leak out path ex- 
Pump”; American Society for Artificial Internal Organs ists. Further, any other leak to or from the medication 
Transactions, Volume XXIII; 1977) describe an implant- reservoir would be sensed by a moisture detector out- 
able infusion pump which comprises a hollow disk sepa- side the reservoir and an indicative informational signal 
rated into two chambers by a bellows. A volatile fluoro- 10 generated. 
carbon in the Outer chamber forces drug from the inner Also at the outlet where medication from the medica- 
chamber through a filter and catheter into a patient. tion reservoir is dispersed is an element for counting 
Filling Of the inner chamber is accomplished by pene- dispensed dosages of medication, which count can be 
trating a self-sealing septum which apparently forms a compared to medication requests, thus providing an 
wall of the inner chamber* The condensation Of the l5 operational indicator and safety feature. If, for example, 
fluorocarbon provides energy for Cyclical pumping. No the pulsatile pump fails to function or its output is 
antechamber* no check for pressure integrity before blocked (e.g. at the catheter), there will be a significant 
no patient or doctor interaction with the device are provided. ms feature would be ofgreat significance in 
contemplated. Detecting the status of such elements and 20 any medication infusion system whether the dispensing 
providing corresponding informational signals are thus pump is implanted or external to the body. 
In programming the medication infusion system, con- not considered. 
cusses current trends in the drug pump field. Prepro- 25 wired limit is also included to limit the dispensing of 
food intake is mentioned. Efforts in the development of gram, the hardwired limits will inhibit the pulsing of a bellows pump are also discussed. Spencer further excessive medication into the patient and an informa- mentions the use of alarm sounds if a pump fails to tional signal to the patient will be provided. provide drug in accordance with the preprogrammed 30 
Safe filling is also a concern in the present invention. rate. The Spencer article generally discusses drug dis- 
problems. As in other cited systems redundant safty tion, a matching procedure of patient to medication is 
features such as providing an antechamber; leak detec- employed. If an identification code on the medication 
tion; providing distinctive subcutaneous or 35 does not match a patient identification code, it will not 
audio alarm to indicate various selected conditions and be injected into the medication reservoir from which 
deviations in nominal performance; providing a safe dispensing takes place. Like the bar coding of consumer 
method of programming the device regardless of work, products, a S h i h  medication coding correlated to a 
food-intake, or time schedules; and the patient and his needs is provided. An attempt at refilling 
reservoir pressure below ambient body pressure so that 4 a Patient’s unit with improper medication will prompt a 
a leak would in body fluids entering the device as warning signal to the physician. Filling the reservoir is 
opposed to a fatal dose of drug the body (at a also performed in a safe manner, with an indicator sig- 
high, constant pressure) are not considered. nal being activated when the reservoir is filled. 
The informational signal to be provided when an 
SUMMARY OF THE INVENTION 45 improper operational condition is sensed can take vari- 
In a field where safety and reliability are paramount, OUS forms. A subcutaneous electrical, thermal, or acous- 
the present invention provides extensive redundancy to tic Signal in the form of a Single Pulse Or multiple Pulses 
prevent and, if appropriate, inform a patient of less than which can have various pulse widths or pulse intervals 
optimal system performance. can inform the patient of an existing or potentially unde- 
According to the medication infusion system de- 50 sired operating condition or proper operation if that is 
scribed in the above-identified, related patent applica- desired. In addition, provision is made for a physician to 
tion, an antechamber is provided, which is filled with interrogate the medication infusion system to determine 
saline solution or a bacteriacidal solution or a non-lethal exactly what the condition is that is causing the alarm. 
volume of the medication, to act as a buffer between the For some patients the physician may wish to have the 
medication intake point and a medication reservoir in 55 same informational signal provided for each different 
the device. The medication reservoir may contain a alarm with a unique signal (depending on the cause of 
lethal dose of drug or other medication if released all at the alarm) being made known by telemetry but only 
once. The input to the medication reservoir is thus iso- discernible by the physician. 
lated from the body by a filter, a one-way inlet valve, The physician could also be provided with a means to 
the antechamber and a septum which serves as a self- 60 disable any of the informational signals for a variety of 
sealing opening to the antechamber. All of these ele- reasons. For example, if the moisture detector became 
ments are provided to prevent the leakage of medica- defective so that it incorrectly caused an informational 
tion from the medication reservoir into the body. As a (alarm) signal to be generated, then the physician may 
further measure however, the medication reservoir is elect to turn that alarm off rather than surgically remov- 
maintained at a pressure below the ambient body pres- 65 ing the device implanted in the patient. A telemetry 
sure. Thus, even if the inlet valve and septum leak, body means can be provided to determine which informa- 
fluids would enter the antechamber and ooze very tional signals are enabled and which, if any, are dis- 
slowly into the medication reservojr through the flow- abled. 
filling or during operation, no programming means, and count discrepancy, and an informational signal will be 
an by Spencer Diabetics: an venience and safety are major concerns. Thus, in ad& 
electronic pancreas;” IEEE-Spectrm’ June, 1978) dis- tion to a programmable rate of medication input, a hard- 
gramming the rate Of drug flow Over time depending On medication. If requests exceed the limits set by the pro- 
penser technology but fails to address many specific To assure that the patient receives the proper medica- 
4,784,645 
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Various informational signals to indicate low battery 
voltage, medication reservoir nearly empty of medica- 
tion, and medication infusion pump switched off are 
provided which could enhance the safe operation of an 
implanted or external pump in a medication infusion 
system. Additionally, indications are given when refill 
of the medication reservoir has been completed and if 
moisture is detected either between the reservoir and 
the outer casing or inside the compartment housing the 
electronics portion of the medication infusion system. 
DESCRIPTION OF THE DRAWINGS 
FIG. 1 is an illustration showing a general block 
diagram of a medication infusion system employing the 
present invention. 
FIGS. 2 and 3 are illustrations showing a front cut- 
away and a top perspective view, respectively, of a 
medication dispensing unit in a medication infusion 
system. 
FIG. 4 shows, in detail, a top view of a combination 
moisture detectorhwitching unit which senses when 
various predetermined operating conditions exist. 
FIG. 5 is a cross-section side view of the combination 
moisture detectorhwitch unit shown in FIG. 4. 
FIG. 6 shows one embodiment of an informational 
signal generator. 
FIG. 7 is a cross-section view of one embodiment of 
a pump which may be included in the present system. 
FIG. 8 is a block diagram showing electronic compo- 
nents of the system. 
FIG. 9 shows signals representing various pulse- 
coded alarm patterns used in informing a patient of 
various deviations from normal operating conditions. 
DESCRIPTION OF THE INVENTION 
Refemng to FIG. 1, the various portions of a pro- 
grammable medication infusion system are shown. A 
medication dispensing unit 10 inplantable in or external 
to a patient’s body can be programmed either by the 
medication programming system 12 or by the patient is 
programming unit 14. Commands from the medication 
programming system 12 emitted from the communica- 
tion head 16 are transmitted to electronics in the medi- 
cation dispensing unit 10 in order to program and effec- 
tuate the infusion of medication into the body in a safe, 
controlled fashion. Furthermore, the communication 
head, 16, is used to receive signals telemetered out of 
the implanted unit 10. Thus, the communication head, 
16 is really a command transmitting antenna and a tel- 
emetry receiving antenna. This antenna might typically 
be a few hundred turns of fine copper wire having ap- 
proximately the same diameter as a similarly configured 
antenna in the implanted medication dispensing unit 10. 
The communication head 16, might also provide a 
source of an alternating magnetic field coupled to the 
similar coil in the implanted unit 10, to provide energy 
for recharging a rechargeable cell contained in 10. Fur- 
thermore the inductively coupled energy could be used 
to power the command and telemetry systems of the 
implanted unit 10. 
The medication programming system 12 is also capa- 
ble of reading information telemetered out from the 
medication disuensing unit 10. which information re- 
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unit 10. A medication injection unit 18 is connected to a 
double hypodermic syringe 20 which is used to provide 
medication to a medication reservoir 22 (shown in FIG. 
2) included within the medication dispensing unit 10. 
Fill commands to the medication injection unit 18 ema- 
nate from a medication programming unit 24. A pa- 
tient’s programming unit 14 (which may also communi- 
cate, by inductive transmission for example, with the 
medication dispensing unit 10) is controlled by the user 
(typically the patient) to request doses of medication, 
Le. to obtain self-medication. The dispensing of dosage 
requests is limited by various elements included in the 
programmable memory units (shown in FIG. 8 as 106 
and 108) and in the hardwired limit controls (shown at 
110 and 112 in FIG. 8) all of which are found in the 
medication dispensing unit 10. 
To recharge a power cell 26 (see FIG. 8) contained 
within the medication dispensing unit 10 (when the 
power cell 26 is a rechargable type), an external charg- 
ing head 28 connected to a battery charging unit 30 is 
included. The need for the charging head 28 and battery 
charging unit 30 can be obviated by the inclusion in the 
medication dispensing unit 10 of a power cell 26 (such 
as a lithium cell) which is of sufficient lifetime to negate 
the need for recharging. Where the implantable portion 
10 is, in fact, not implanted but is employed externally 
other methods of recharging or even replacement of the 
power cell may be employed. The medication program- 
ming unit 24 provides output to a paper printer 32 
which provides hard, readable output that can be 
readily interpreted by a physician. 
Referring now to FIGS. 2 and 3, the medication 
dispensing unit 10 of an implantable programmable 
medication infusion system is shown. Medication is 
provided to the medication dispensing unit 10 by means 
of a hypodermic syringe 20 which penetrates the skin 34 
and passes’through a conical aperture 35 and a self-seal- 
ing septum 36, preferably made of medical grade sili- 
cone rubber or the like, which covers an antichamber 38 
in leak-proof fashion. Medication is introduced into the 
antechamber 38 through syringe 20 at atmospheric pres- 
sure or under pressure the level of which is controllable 
externally. A medication reservoir 22, in which the 
medication is stored under relatively constant pressure, 
is fed from the antechamber 38 via a ceramic filter 43 
and a one-way inlet pressure valve 44 which permits 
flow only from the antechamber 38 into the medication 
reservoir 22 when the pressure differential between 
them exceeds a predetermined threshold. 
50 The inlet c e k i c  filter 42 surrounds the antechamber 
38 and performs various functions which enhance the 
safety of the implantable portion 10 particularly in an 
implant environment. Besides filtering contaminants 
from medication being fed into the medication reservoir 
55 22, the ceramic filter 42 serves to limit the rate of medi- 
cation flow from the antechamber 38 into the reservoir 
22 or, conversely, from the reservoir 22 into antecham- 
ber 38 should the inlet pressure valve 44 leak. Should 
the septum 36 leak, the ceramic filter 42 together with 
60 the inlet pressure valve 44 prevents the inflow of body 
fluids into the medication reservoir 22. Further, should 
the inlet pressure valve 44 and the septum 36 both leak 
or otherwise deviate from odmal  uerformance. the 
lates to the amount -of medication dispensed over a filter 42 would permit only a siow flow of body fluids to 
specified time period as well as other data of value to 65 enter the medication reservoir 22, until body ambient 
the physician. Further, the medication programming pressure is achieved, at which time some medication 
system 12 is capable of calibrating the medication per could diffuse through the ceramic filter 42 but at a rate 
pulse which is dispersed by the medication dispensing that would not be hazardous to a typical patient in 
4,784,645 
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which the system would be implanted. Furthermore, of FIG. 8, to the medication programming system 12 of 
when this occurs an informational signal would be gen- FIG. 7, to stop the infusion of medication. 
erated. If body fluids leak into the medication reservoir 22, 
A liquid-vapor pressurant chamber 45 is separated the flexible diaphragm 46a will move out further, result- 
from medication reservoir 22 by a flexible diaphragm 5 ing in the movable electrical contact 48 being forced to 
4&. The liquid-vapor volume in the liquid-vapor cham- make electrical contact with the metal surface 51 Of 
ber 45 preferably comprises a saturated vapor in equilib- FIG. 4. This switch closure would cause the program- 
dum with a small amount of Freon 113 liquid. Over mable information signal generator 70 of FIG. 8 to 
normal body temperatures, Freon 113 has a linear pres- Provide an appropriate hfOm~&nal Signal which 
sure characteristic ranging from -4 psig (at 98”) to 10 would be sent to warn the patient. By way of example, 
approximately -2.5 psig (at 104” F.). Using Freon 113, the signal to the patient might be in the form of an 
the medication reservoir 22 will be maintained at a electrical “tickle” stimulation applied subcutaneously 
altitudes of 8500 feet. For patients who may live above posed on the upper surface of the unit 10 (see FIG. 2). 
pressure below that of the human body pressure up to by means of a stimulation electrode 51a of FIG. 8 dis- 
the altitude, other fluorocarbons at lower pressure may 15 Another useful means for warning the patient would be 
be employed. In this way, should both the septum 36 by means of an acoustical transducer tYPicdb within 
and the inlet pressure valve 44 leak, the effect would be provide the patient the imp1anted device that 
to cause body fluids to diffuse slowly through the inlet 
ceramic filter 42, into the medication reservoir 22 rather 13, but in the absence Of 
than to have a rapid flow of medication enter into the 20 moisture, the electrical resistance between the depos- 
ited metal surfaces 52 and 53 which collectively form body where it could cause harm to the patient. Because the moisture detector 54 (see FIG. 8) is greater than 1 
medication reservoir 22, medication will not flow from uid-vapor chamber 45, either through a leaky flexible the reservoir 22 into the body. As the amount of medi- 25 diaphragm 46a of if body fluids leak through the sealed 
cation in the medication reservoir 22 varies, the flexible Outer 6o into the liquid-vapor chamber 45, then 
diaphragm 46a up Or down’ with the Freon l3 the moisture detector 54 will experience a detectable 
liquid to provide an essentially constant pressure which faces 52 and 53. If this occurs, moisture detectors 54 
One standard atmosphere and 30 initiates an informational signal to be sent to the patient 
below normal body pressure. A medication reservoir 22 to indicate a leak in the implanted unit 
cient for most applications. This amount of concen- ber 45 are separated from the other portions of the 
trated medication, insulin for example, could be fatal if medication dispensing unit by wall 55 (forming the 
injected Over a short time. To prevent fatal leakage, the 35 top of reservoir 22, as viewed in FIG. 2) and fluidically 
dosage volume, e.g. less than 10% the size of the ofthe inlet pressure valve 4 and a pump inlet valve 73 
cation reservoir 22. In the worst case, if the medication (see FIG, 7) which connects the reservoir 22 to a pulsa- 
reservoir 22 had a leak into the antechamber 38 which tile pump 57 (shown in detail in FIG. 7). The remaining 
also had a leak, only medication diluted with incoming 40 elements of the implantable medication dispensing unit 
body fluids due to the pressure differential would ini- 10 are shown in FIG. 2 above and isolated from the 
tially enter the body. Such flow would be at a relatively reservoir 22 (by wall 55) and include an electronics 
slow diffusion rate because there would be zero pres- compartment or section 56 containing a power cell 
sure differential and because there is very restrictive subsection 58. is readily seen in FIG. 2, an Outer 
flow Dath. Under these conditions, the likelihood of 
with an 
In the presence Of Freon 
Of the pressure between the body and the megohm. If however, moisture is released into the liq- 
being converted either from liquid to vapor Or vapor to decrease in electrical resistance across the metal sur- 
a’ways be 
having a of approximately 10 cc would be suffi- The medication reservoir 22 and liquid-vapor cham- 
Of the antechamber 38 is designed to have a safe isolated from the other elements of the system by means 
leakaie being fatal is minimized. As readily seen in FIG. 
2, varying the size or shape of the medication reservoir 
22 would be a simple modification because of the ar- 
rangement of elements in the system. A very important 
characteristic of the reservoir is that it is all metal (in- 
cluding the diaphragm 46u of FIG. 2.) so that no mois- 
ture can diffuse out of the reservoir 22 so that could 
damage any of the electronics in the implanted unit 10. 
Included in the liquid-vapor chamber 45 of a com- 
bined diaphragm position switch-moisture detector unit 
46 (shown enlarged in FIGS. 4 and 5) comprising a 
ceramic insulator substrate 47 to which is attached a 
movable electrical contact 48, and deposited metal sur- 
faces 50, 51, 52 and 53. When the medication reservoir 
is being filled, the flexible diaphragm 46a will move 
outward, and when the medication reservoir 22 is full, 
the flexible diaphragm 46a will make physical contact 
with the movable electrical contact 48. Since the flexi- 
ble diaphragm 46u is preferably fabricated of metal and 
is therefore an electrical conductor, it will close an 
45 cover 60 isolates the medication reservoir chamber 22 
and liquid-vapor pressurant chamber 45 as well as the 
pump 57 and the electronics compartment or section 56 
(and the power cell subsection 58) from the external 
environment. A moisture detector 59, of the same de- 
50 sign as detector 54 described above, would be located in 
an electronics section 56 (of FIG. 2) so that it could 
detect and provide an informational signal to the patient 
if either a medication leak occurs through the wall 55 or 
body fluids penetrate the top portion of the sealed outer 
An informational signal generator 70, such as that 
shown in FIG. 6, can be used in signalling or alerting a 
patient of a predetermined condition or in checking the 
medication dispensing unit 10 (of FIG. 2). The genera- 
60 tor 70 has a plurality of inputs A1 through AN. The A1 
through ANinputs are provided by a command decoder 
(104 of FIG. 8), the inputs A1 through AN selectively 
switching elements Si through SN in amplitude select 
element 72 to provide 2N possible, programmable volt- 
65 age levels. The programmable voltage level is applied 
55 cover 60. 
electrical circuit through the movable electrical contact - 
48 and the deposited metal surface 50 which can be used 
to send out a signal by the telemetering transmitter 105 
to an amplifier transistor circuit 74, whichis biased-by a 
voltage VA. The output signal Vo of the circuit 74 can 
be applied to a lead 75 in contact with the patient if an 
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input (VIN) to a FET 76 is provided. A capacitor 77, 
preferably of one microfarad, is located between the 
alarm output signal Vo and the patient to generate a 
patient-sensed voltage across load Rp ranging between 
one and ten volts selectable in programmable steps. The 5 
load Rpcan provide electrical stimulation (e.g. by means 
of the stimulation electrode 51u in FIG. 2), heat, or 
audio alarm output to inform the patient. In the case of 
tection, pulse count discrepancy, excessive pulse re- 
quest, low battery voltage, and the like can thus stimu- 
late an alarm signal by entering a line like V ~ y o f  FIG. 
6. 
For example, the pulse rate detector 84 sends trans- 
ducer pulse rate information to the pulse recorder 82, 
which information is compared by comparator circuitry 
in the pulse recorder 82 to the electrical pulses over the 
an information4 (alarm) signal provided by electrical 
stimulation, the load Rp is the electrical load caused by 
the patient’s tissue and fluid surrounding the alarm elec- 
trode 51a. When the FET 76 conducts, the load R,, is 
short-circuited. When the FET 76 is not conducting 
(there is no VIN), a stimulating signal through the load 
R,, can be effected. The information signal generator 70 
input VIN may be high (or “on”) when any one of a 
plurality of selected conditions is detected and sig- 
nalled, such as: the fill limit of reservoir 22 has been 
reached (when diaphragm 46u connects to switch 
contact 48 in FIG. 5), body fluids have entered reser- 
voir 22 (when contact 48 connects to surface 51), un- 
wanted moisture has been detected within the unit 10 
(by detector 54 or 59 in FIG. 8), and the like. 
The pump 57 shown in FIG. 7 is discussed in detail in 
the above-referenced patent application. In an output 
chamber of the pump 57 is a tranducer 78 which senses 
when a pulsatile dose of medication is dispensed. Trans- 
ducer 78 detects pressure build-up in the output cham- 
same period from the coil 79. A discrepancy between 
10 the two counts results in a signal to the information 
signal generator 70 over line 8241, as seen in FIG. 8 
which causes the FET 76 (FIG. 6) to assume a high 
impedance state and a current to pass through stimula- 
tion electrode 51u. As noted earlier, thermal, acoustic, 
15 or other similar stimulation to the body might be used in 
place of or in combination with the electrical stimula- 
tion. 
As seen in FIG. 8, the electronics portion of medica- 
tion dispensing unit 10 (enclosed by dashed line 56 of 
20 FIG. 8) communicates with a communication head 16 
which is external to the body (for both implanted and 
external embodiments). Communication may be by wire 
for external embodiments or, for implantable or external 
embodiments, by radiant energy (in electromagnetic, 
The communication head 16, in the FIG. 8 embodi- 
ment, provides both power and command inputs, as 
well as receiving telemetrv output. More soecificallv, 
25 alternating magnetic, or other remote signal forms). 
ber of pump 57:It may be note‘d that othe; types of input power is irovided by mkans of an kternatiig 
transducers are available which can detect a pulsatile 30 field, e.g. a magnetic field, which is communicated to a 
flow through an output tube. Each pulse of medication pickup coil 92 which is connected to other elements of 
is communicated by the transducer 78 as an electrical the electronics section 56. The pickup coil 91 receives a 
pulse and therefore, based upon prior knowledge of the power signal and passes it on to a full wave rectifier 94. 
volume of medication in reservoir 22 when full and the One rectified output from the full-wave rectifier 94 
volume of medication dispensed for each actuation of 35 enters a battery charge control 96 which provides a 
pump 57, it is obvious that at any given time the current fixed DC charging signal to a power cell 26. The power 
volume of medication remaining in the reservoir 22 can cell 26 can be a nickel-cadmium cell which is readily 
be determined by merely recording a count of the num- rechargeable off a rectified signal at a typical frequency 
ber of pulses produced by transducer 78. To promote a of 20 kHz. Alternatively, a lithium-type solid state bat- 
pulse of medication, a coil 79 (or other similar means of 40 tery can be used instead of the nickel-cadmium cell in 
reciprocating a variable volume pump storage chamber which case the charging circuitry could be eliminated, 
80) is provided with a pulse of electrical energy. the lithium-type battery providing sufficient power 
By comparing the number of electrical pulses to the over a long term, thereby obviating the need for re- 
coil 79 with the number of electrical pulses produced by charging. The power cell 26 provides a biasing voltage 
the transducer 78, an operational check is performed 45 to a switch 98, the output of which enters the pulsing 
and indicates, for example, that the output of the medi- coil 79 previously described. 
cation dispensing system is clogged. Thus, as seen in In addition to providing power to the power cell 26, 
FIG. 8, electrical pulses from the transducer 78 and a rectified power is also introduced to a DC-to-DC con- 
count of electrical pulses to the coil 79 are communi- verter 100 the purpose of which is to provide power at 
cated to and stored in a pulse recorder 82. 50 the proper levels to the various loads in the system. In 
The output of the transducer 78 is also applied to a addition to the AC power signal, pickup coil 92 may 
pulse rate detector 84. The pulse rate detector 84 pro- also receive a train of serial digital bits, e.g. from the 
vides a hard-wired “insufficient rate” command input communication head 16. The digital bits comprise com- 
which provides a programmable lower medication dis- mands for programmable inputs which are conveyed, 
pensing limit. That is, when less than a physician pre- 55 via the pickup coil 92 to a command receiver 102. The 
scribed minimum of medication is delivered to the signals from the command receiver 102 enter a com- 
body, the rate detector 84 signals information signal mand decoder 104 which determines if the digital bits 
generator 70 that an informational (alert) signal to the are in a proper format and, if so, what action in the 
patient is to be generated. To effect this signal, an input system the commands dictate. To allow remote verifica- 
(line 844  to the programmable information signal gen- 60 tion of the information decoded in command decoder 
erator 70 (of FIGS. 6 and 8) is connected through 104, the decoded signals are transmitted back to the 
switch inputs, such as Vmin FIG. 6. Although shown communication head 16 by means of a telemetry trans- 
as a FET switch input, V ~ ~ m a y  provide input to an- mitter 105 and a telemetry coil 107. It should also be 
other form of switch connected to a programmable noted that the full wave rectifier 94, the battery charge 
information signal generator 70 which may have a pulse 65 control 96, the command receiver 102, the command 
coded memory and varied outputs corresponding to decoder 104 and telemetry transmitter 105 could be 
inputs for different conditions (as shown in FIG. 8.) powered only when an AC signal is picked up by the 
Overpressure (from an over-filled reservoir), fluid de- pickup coil 92. As seen in FIG. 8, for example, the 
11 
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command receiver 102 receives operating power from the command decoder 104 can be entered into the hard- 
the full-wave rectifier 94 enabling it to convey signals wired limit control elements 110 and 112. These extra 
from the coil 92 to the command decoder 104. It should pulses can be added to the pulses provided by the base 
be obvious that a power savings is achieved by only rate and the patient-controlled rate memory units 106 
powering the command receiver etc. when necessary 5 and 108, in order to exceed the hardwired base rate and 
and, moreover, prevents the possibility of detecting the hardwired patient-controlled rate, respectively. 
stray signals as commands. To be sure, the power sav- When the rates are exceeded, the information signal 
ings achieved could make possible the use of the afore- generator 70 will provide a signal. In this way, the 
mentioned lithium cell which would not require re- information signal generator 70 can be used to check the 
charging. 10 operation of the limit control elements 110 and 112, 
From the command decoder 104, programmable in- inform the physician of operational problems via means 
puts and other commands can be provided to a number V,, and also familiarize the patient with the correspond- 
of elements. A programmable base rate is entered into a ing stimulation emitted by the Ioad Rp. 
base rate memory unit 106 which stores a value indicat- The programmable information signal generator 70 
ing the number of pulses of medication which are to be 15 also receives inputs from the movable electrical contact 
provided to a patient during a normal preselected per- 48 and the moisture detectors 54 and 59 (see FIGS. 2 
iod of time. A second programmable input is provided and 4). If body fluids leak into the medication reservoir 
to a patient-controlled rate memory unit 108 which 22, the movable electrical contact 48 will make electri- 
stores a value indicating a number of pulses of medica- cal contact with 51, indicating this fault condition to the 
tion that are requested by the patient (with a patient 20 patient by activating the information signal generator 
programming unit 14) to be introduced into the body. 70. If the patient was unconscious, voltage levels on the 
Associated with the base rate memory unit 106 is a patient’s skin at the site of the medication dispensing 
hardwired base rate limit control 110 which sets a maxi- unit 10 could be used by the physician to detect if a 
mum rate that can override requests of the base rate deviation has occurred and could, with a pulse-coded 
memory unit 108 which are excessive. Similarly, a hard- 25 embodiment, indicate which selected deviation in nomi- 
wired patient-controlled rate limit control 112 provides nal performance it was. Further, as previously de- 
a fixed maximum number of pulses which can be pro- scribed, should fluid leak out of the medication reser- 
vided at a time after a meal or at other times and under voir 22 or if body fluid should leak in through the enclo- 
other conditions such as exercise. As long as the base sure 60, the moisture detector 54 would sense such 
rate and patient-controlled rate values stored in mem- 30 leakage and, as shown in FIG. 8, would provide input to 
ory units 106 and 108 respectively, do not exceed the the information signal generator 70. Similarly, moisture 
hardwired values fixed within limit controls 110 and detector 59 would signal the presence of medication or 
112, respectively, an output pulse is provided to the body fluid in the electronics compartment 56. Still an- 
switch 98 to stimulate a pulse output from pulsing coil other input to the information signal generator 70 
79. Should the rate of either memory unit 106 or 108 35 comes from the power cell 26 associated with the tran- 
exceed the hardwired limits in the limit control ele- sistor switch 98. The voltage level of the power cell 26 
ments 110 or 112, respectively, a “rate request exceeds is thus communicated to the signal generator 7 0  a stim- 
limit” signal is fed from the limit control element 110 or ulation signal being generated when the battery voltage 
112 into the programmable information signal generator is below a predetermined level. 
70 which provides an electrical signal to the load Rp. 40 It should be noted that the various mentioned condi- 
The patient (in one form of the invention) is informed tions in the system result in stimulations each of which 
by means of a stimulation that more medication than may all be the same or which may be different in stimu- 
permitted has been requested. lation pulse amplitude, duration, periodicity, interpulse 
It should be noted that the signal to the load Rp, e.g. spacing or other coding. For example, the stimulation 
an electrode, can serve the dual function of not only 45 may range between one to ten volts; may vary in fre- 
providing the patient with a subcutaneous, heat, or quency over a wide range; and, most importantly, a 
audible stimulation but may also be detected by the variety of unique pulse patterns may be used to indicate 
communication head 16, via signal transfer means Vo, the various selected conditions or deviations in nominal 
and may be communicated to the physician, thereby performance. 
indicating that a deviation from optimal system status 50 As discussed previously, additional signals to initiate 
has occurred. As shown in FIG. 8, the load Rp will be an informational signal to the patient are derived from 
isolated and electrically insulated from the outside of pulse count information in the pulse recorder 82 and 
the enclosure 60 of the medication dispensing unit 10. pulse rate detector 84 of FIG. 8 and might also be de- 
A particularly significant feature of the invention rived from any of a variety of optical, capacitive, induc- 
resides in the programmability of the information signal 55 tive, liquid crystal, or other reservoir level measuring 
generator 70 based on input commands from the com- elements which might be utilized to inform the patient 
mand decoder 104. The voltage produced by the signal (or physician) when say only 10% or a 5 days supply of 
generator 70 across the load Rp can be varied in re- the medication remains in the reservoir. 
sponse to signals emanating from the communication Referring to FIG. 9, three pulse-coded deviation 
head 16 and channelled through the command receiver 60 signals are illustrated. In FIG. 9(A), two 1.5 second 
102 to the command decoder 104 and into inputs A1 signals five seconds apart are repeated at fifteen minute 
through A, of amplitude select element 72 (3hown in intervals to indicate insufficient medication rate. In 
FIG. 6). FIG. 9(B), two 1.5 second signals ten seconds apart are 
In addition, in order to check the proper operation of repeated at thirty minute intervals to indicate a moisture 
the system, the command decoder 104 can receive test 65 leak. In FIG. 9(C), two 1.5 second signals fifteen sec- 
signals which can stimulate actual occurrences to deter- onds apart are repeated every forty-five minutes to 
mine whether the circuitry in the electronic section 56 indicate that the medication reservoir contains body 
is operating properly. For example, extra pulses from fluids. Similar coding or a variation thereof can also be 
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employed to indicate low battery voltage and undesir- a means for providing an information signal when 
ably high medication rate requests. said counting means reaches a certain count 
It may also be desirable to have the same pattern for number. 
all alarms, but have a unique informational signal be 2. The apparatus of claim 1, wherein said volume 
provided only for the physician to determine the spe- 5 detecting means further comprises a means for storing a 
cific cause of that alarm. If that was done, then any one valve for Said count number. 
of the signal formats of FIG. 9 could be used as the 
alarm pattern for the patient. 
various other modifications, adaptations and alter- 
ations are of course possible in light of the above teach- lo 
ings. Therefore, it should be understood at this time that 
within the scope of the appended claims the invention 
may be practiced otherwise than as specifically de- 
scribed. 
3. The apparatus of claim 1, further ComPrisiW 
an acoustic transducer; and, 
a means responsive to said informational signal for 
4* The apparatus Of 
a tickle means adapted for implantation for applying 
a subcutaneous electrical tickle to an intracorpor- 
ea1 location; and, 
a means responsive to said informational signal for 
actuating said tickle means. 
5. A system for infusing medication into a patient 
actuating said acoustic transducer- 
& further comprising: 
15 What is claimed is: 
1. An apparatus for infusing medication into a living 
a medication reservoir means for storing medication ComDriSing: 
body comprising: 
- 
20 to be infused; a pulsatile pump means operably coupled to said 
reservoir means for pumping a dose of medication 
in response to an electrical pulse input; 
means for applying said electrical pulse input to said 
an infusion output from which pumped medication 
exits the system and is dispensed to the patient; 
a sensing means, disposed at the infusion output, for 
sensing the actuation of said pumping means and 
the dispensing of a dose of medication and trans- 30 
ducing an electrical signal corresponding to each 
dispensed dose; and, 
a volume detecting means for detecting the volume of 
medication dispensed from said reservoir means, 
a counting means, operably coupled to said sensing 
means for counting the occurrences of said elec- 
. trical signal corresponding to said dispensing 
dose, and 
pumping means; 25 
and including, 35 
40 
. -  
a pulsatile pump means for pumping a dose of medica- 
tion in response to an electrical pulse input; 
means for applying said electrical pulse input to said 
pumping means; 
an infusion output from which pumped medication 
exits the system and is dispensed to the patient; 
means, disposed at the infusion output, for sensing the 
actuation of said pumping means and the dispens- 
ing of a dose of medication and transducing a single 
corresponding electrical pulse for each dispensed 
dose, 
means, receiving inputs from the electrical pulse 
transducing means and from the electrical pulse 
applying means, for comparing the number of ap- 
plied electrical pulses with the number of trans- 
duced electrical pulses; and, 
means, connected to the comparing means, for gener- 
ating an informational signal when the number of 
transducer electrical pulses deviate from the num- 
ber of applied electrical pulses. * * * * *  
45 
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